Introduction: Weigao Group is located in the beautiful coastal city of Weihai. The group has 18 subsidiaries, of which Shandong Weigao Group Medical Polymer Products Co., Ltd. is a listed company in Hong Kong, and has formed a development pattern of medical devices, pharmaceuticals, aerospace electronics, investment, real estate and other five major business areas going hand in hand. The Group now has total assets of more than 4 billion yuan, more than 9,000 employees, the factory covers an area of 1.25 million square meters, with more than 200,000 square meters of purification workshop in line with GMP requirements, and can produce more than 300 varieties of nearly 30,000 specifications of medical devices, pharmaceuticals and other products. Ltd-Corporate Profile Over the past 20 years, Weigao has adhered to the policy of "pioneering, innovation, pragmatism and consolidation", and has taken scientific and technological innovation as the driving force, backed up by scientific management, which has promoted the sustained, rapid and healthy development of the enterprise. The company has developed disposable infusion supplies, surgical sutures, implantable medical catheters, cardiac stents, indwelling needles and all kinds of shaped needles, blood purification series products, orthopaedic series products, electromechanical integration medical devices, therapeutic injections, bio-diagnostic reagents, artificial plasma and other medical devices and medicines, and has set up a very large scale of medical supplies industrial park, orthopaedic materials industrial park, medicine and science and technology industrial park, aerospace electronic product production, and the production of medical products. Weigao Group has established a very large-scale medical supplies industrial park, orthopedic materials industrial park, pharmaceutical industrial park and aerospace electronic products production base, and has now become the largest single-use medical device manufacturer in China. Weigao Group adheres to the development strategy of "people-oriented, science and technology first", improves the scientific management mode, and perfects the management system. The company is the first in the industry to introduce and use advanced management software such as ERP and KPI, and its products have passed CE, ISO9001, ISO13485 and 3C certifications, and some of its products have passed the U.S. FDA listing license. The company's testing center has been accredited by the National Laboratory Accreditation Committee. The persistent pursuit of science and technology has given Weigao Group room for survival and development. The company has been identified by the Ministry of Science and Technology of the People's Republic of China and other ministries and commissions as "National Torch Plan Key High-tech Enterprises", "National High-tech Research and Development (863) Program Achievement Industrialization Base", "National Enterprise Technology Center", and "National Enterprise Technology Center". "The company also has a post-doctoral workstation. The company actively carries out production, learning and research cooperation, and works closely with Changchun Institute of Applied Chemistry of Chinese Academy of Sciences, Dalian Institute of Chemical Physics of Chinese Academy of Sciences, Shenyang Institute of Metals of Chinese Academy of Sciences, the Third Military Medical University, 301 hospitals, Harbin Institute of Technology (Weihai), and other scientific research institutes and colleges and universities, and employs 10 academicians of the two colleges to be the consultant, and relying on their talents and scientific research strength, offsite the establishment of the nine Weigao Group research and development centers, based on the Based on the high point of the industry, the company digests and absorbs the international cutting-edge technology and develops high-tech products with independent intellectual property rights. More than 60 products have reached the advanced level at home and abroad, and many of them have filled the gaps in the country. 20 products have been selected for various national projects such as the National 863 Program, the National Key Torch Program, the National High-Tech Industry Demonstration Project, and the National Key New Products, etc. Among them, the drug-coated stent system, pre-filled syringes, orthopaedic implantable materials, etc. have broken the monopoly of the Chinese market held by foreign companies. Weigao Group persistently implements the famous brand strategy and cultivates famous brands. The trademark of "JERUI" has been recognized as "Famous Trademark of China", and "JERUI Brand Single-use Sterile Infusion Medical Devices" has been awarded the title of "Famous Brand Product of China". The brand of "JERY" was recognized as "China Famous Trademark" and "JERY Disposable Sterile Infusion Medical Devices" was awarded as "China Famous Brand Product". The company has established more than 100 sales offices in more than 30 provinces, municipalities and autonomous regions, and has established long-term and stable relationships with more than 7,000 hospitals, 400 blood stations and 1,800 commercial companies. Our products not only sell well in more than 30 provinces, municipalities and autonomous regions in China, but also directly exported to the United States, the European Union, Russia, South Africa, Brazil and other more than 50 countries and regions.